US 11446357
Method for treating disease using FOXP3+CD4+ T cells
granted A61KA61K38/1709A61K38/177
Quick answer
US patent 11446357 (Method for treating disease using FOXP3+CD4+ T cells) held by Kyverna Therapeutics, Inc. expires Mon Sep 15 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Kyverna Therapeutics, Inc.
- Grant date
- Tue Sep 20 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Sep 15 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 15
- CPC classes
- A61K, A61K38/1709, A61K38/177, A61K38/1774, A61K38/1793